Enabling biomedical startups to turn their R&D into life-changing solutions is in our DNA. The Incu-Bio Programme is the most ideal platform to provide our startups the best business support, investment opportunities, connections to our biomedical ecosystem, lab facilities and financial aid to bring your ideas to fruition.
We have built the most thriving biotech ecosystem to help you make big strides in this competitive healthcare landscape. Incu-Bio Programme is your first step to build a healthier world.
This programme is designed for the next generation of changemakers in biomedical science. You should apply for Incu-Bio if you are:
The co-incubation programme between HKSTP and Astrazeneca is to accelerate innovation and support biomedical startups in their mission to develop integrated oncology solutions. In the programme, AstraZeneca will support startups and assist in connecting them with industry stakeholders and partners, to provide a clearer understanding on industry information and related opportunities. Additionally, AstraZeneca will also leverage its existing networks with Mainland China and global markets to provide platforms for exploring opportunities overseas.
Co-managed by HKSTP and GuangZhou KingMed Diagnostics Group Co., Ltd (KingMed), this scheme targets diagnostics and in-vitro diagnostics (IVD) startups in Hong Kong. On top of existing Incu-Bio Programme’s benefits, incubatees will also receive professional coaching and advice on IVD/diagnostic platform development, go-to-market strategy, advice on regulatory affairs etc., and have non-exclusive access to the GMP manufacturing facilities in Guangzhou.
For any enquiries, please contact IncuBio Team by email: email@example.com.